Last reviewed · How we verify
Skin and Skin Structure Proteus Infection
Approved treatments
- Ramycin
Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins. - Garamycin · Merck & Co.
- Cefaprin · Bristol-Myers Squibb
- Tobi · Novartis
- Unasyn · Bristol-Myers Squibb
- Unasyn · Pfizer
- Pipracil
Pipracil works by inhibiting bacterial cell wall synthesis, ultimately leading to cell lysis and death. - Ciprofloxacine · Poitiers University Hospital
- Vantobra · Pfizer
- Gentamicin · Merck & Co.
- Cefadole
Cefadole works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death. - Nebcin · University Hospital, Lille
- Ceftriaxon · Centre Hospitalier Universitaire Vaudois
- Azactam · Bristol-Myers Squibb
Aztreonam inhibits bacterial cell wall synthesis, acting as a bactericidal agent. - Arikayce Kit · Bristol-Myers Squibb
Amikacin works by binding to bacterial ribosomes, inhibiting protein synthesis and ultimately killing the bacteria. - Fortaz · Pai Holdings Pharm
Fortaz works by binding to penicillin-binding proteins on bacterial cell walls, preventing them from forming a strong cell wall and ultimately leading to bacterial cell death. - Mefoxin In Sodium Chloride 0.9% In Plastic Container
- Cefotan
- TICARCILLIN
- Ticarcillin
- Fortaz · Pai Holdings Pharm
Bactericidal agent inhibiting bacterial cell wall synthesis with beta-lactamase resistance. - Noroxin
- Floxin
- Epocelin
- Cipro · Bayer AG
- Rocephin · Generic (originally Roche)
- Ceftazidim · Tel-Aviv Sourasky Medical Center
- Ofloxacine · Assistance Publique - Hôpitaux de Paris
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Skin and Skin Structure Proteus Infection patent landscape — cliff calendar, originator estates, attackable patents
- Skin and Skin Structure Proteus Infection treatment landscape brief
- Skin and Skin Structure Proteus Infection treatment updates RSS
Frequently asked questions about Skin and Skin Structure Proteus Infection
What drugs treat Skin and Skin Structure Proteus Infection?
Tracked treatments include Ramycin, Garamycin, Cefaprin, Tobi, Unasyn, Pipracil, Ciprofloxacine, Vantobra.
What is the treatment for Skin and Skin Structure Proteus Infection?
Standard treatment for Skin and Skin Structure Proteus Infection includes Ramycin, Garamycin, Cefaprin, Tobi, Unasyn. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Skin and Skin Structure Proteus Infection patent cliff · Skin and Skin Structure Proteus Infection CI report
- Treatment: Ramycin
- Treatment: Garamycin · Merck & Co.
- Treatment: Cefaprin · Bristol-Myers Squibb
- Treatment: Tobi · Novartis
- Treatment: Unasyn · Bristol-Myers Squibb
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing